A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
Other posts you may like
Virtual event October 04-08, 2021
We are proud to announce the successful transfer of ownership of emka TECHNOLOGIES.
Virtual Panel Discussion September 23rd at 11:00am EST
Dr. Alex Carll explains how he uses ecgAUTO to analyze ECG, blood pressure, and left ventricular pressure in rodents.